Winter Park, Florida–(Newsfile Corp. – March 27, 2025) – Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine and healthcare innovation, is excited to announce the opening of its first satellite location in Tinton Falls, New Jersey. This expansion is made possible through a strategic shared space agreement with Keep Glowing Medical Spa and renowned physician Dr. Michael Ellis, blending cutting-edge stem cell therapies with an established wellness hub.
Located within Keep Glowing Medical Spa, the new satellite site will operate under Adia Nutrition’s medical division, Adia Med, offering FDA-compliant regenerative treatments such as AdiaVita (umbilical cord stem cells with 100 million viable cells and 3 trillion exosomes per unit) and AdiaLink (3.5 trillion exosomes per unit). These therapies, produced in partnership with an FDA-approved laboratory, meet Section 361 of the Public Health Service Act standards for minimal manipulation and homologous use, targeting conditions like inflammation, autoimmune disorders, and musculoskeletal issues.
https://keepglowingmedicalspa.com/
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/246027_keep_glow_website.jpg
“We’re proud to collaborate with Keep Glowing Medical Spa and Dr. Michael Ellis to bring our regenerative solutions to Tinton Falls,” said Larry Powalisz, CEO of Adia Nutrition Inc. “This shared space partnership taps into Keep Glowing Medical Spa’s top-tier facility and Dr. Mike Ellis’s exceptional expertise, letting us bring transformative care to you in a cost-effective, community-centered way. It’s a seamless blend of innovation and a personal approach that puts patients first.”
Dr. Michael Ellis, a respected figure in integrative medicine, will oversee clinical operations at the Tinton Falls location, ensuring patients receive personalized, high-quality care. Keep Glowing Medical Spa’s established reputation for advanced aesthetic and wellness services complements Adia Med’s mission, creating a seamless integration of regenerative therapies into their offerings. This partnership marks the first step in Adia Nutrition’s plan to expand through similar collaborations nationwide, following the successful launch of its flagship clinic in Winter Park, Florida, in January 2025.
Dr. Michael Ellis
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/246027_dr__michael_ellis.jpg
The Tinton Falls satellite will provide patients with access to Adia Med’s ethically sourced, lab-verified stem cell products without the need for international travel. By sharing space, Adia Nutrition reduces overhead while tapping into an existing patient base, setting a scalable model for future growth in the $15.1 billion global stem cell market.
For appointments or inquiries, contact Keep Glowing Medical Spa at 848-217-2662 or Adia Med at ceo@adiamed.com / 321-788-0850. Investors and media can learn more about this milestone in Adia Nutrition’s journey to redefine healthcare.
For questions, inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/246027
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…
